Edward Pesicka, President and CEO, announced a definitive agreement with Platinum Equity to sell the Products & Healthcare Services (P&HS) segment, including both the Medical Distribution and Global ...
The company reaffirmed 2025 full-year guidance: revenue between $2.76 billion and $2.82 billion, adjusted net income between $1.02 and $1.07 per share, and adjusted EBITDA between $376 million and ...